Blog

Getting ready for ASH 2019: Perspective from the ZoomRx hem-onc panel

The ASH 2019 Annual Meeting kicks-off this Saturday (12/7) in Orlando. Our survey of 51 practicing hematologists-oncologists indicated a great deal of excitement and anticipation, as they prepare for the meeting.In

Cardiologists share their perspective on The Medicines Co.'s inclisiran and other key events from AHA's 2019 Scientific Sessions

Following AHA 2019 Scientific Sessions, Novartis announced its intention to buy The Medicines Company for nearly $10B, based on promising results on its small interfering RNA (siRNA) therapy, inclisiran.The therapy targets PCSK9

JAKs continue to capture attention, new MOAs stir excitement at ACR 2019

This year’s annual meeting held November 8-13 did not disappoint according to a ZoomRx survey with 35 rheumatologists who attended the conference.

Associate Principal Kat Lynch on working in a team-based environment and appreciating malaise-era cars.

Kat Lynch is an Associate Principal in our Boston office. She’s been at ZoomRx for over three years and has worked in pharma market intelligence for over 20. Kat’s deep understanding

Oncologists on ESMO 2019 and the Potential Impact of Key PARP Inhibitor Data

Following this year’s ESMO annual meeting we asked a group of oncologists practicing in the US to weigh in on Europe’s biggest oncology conference. Oncologists expressed general excitement about the meeting,

Evaluating Print vs. Digital Aids in Oncology

Equipping reps with digital visual aids is a time and cost-intensive exercise. Consequently, sales leadership teams find themselves grappling with the questions:The conventional logic is that digital aids enable sales reps to

We’ve tracked oncology promotional efforts for 120+ brands across 60,000 interactions over the last 5 years.

Oncology sales forces are complex and nuanced. They carry multiple products and indications, often conveying multiple themes in the same interaction, given the breadth of indications a typical oncologist treats. As a result, an oncology interaction is a prioritization exercise...

Giving Back by Taking a Survey

The most rewarding part of the ZoomRx research experience is successfully funding the treatment of a deserving patient.Healthcare professionals (HCPs) are busy. The decision to participate in research is always a trade-off

Oncologists reflect on ASCO 2019

The data shared at this year's ASCO Annual Meeting moved the field of clinical oncology forward.Our survey with over 60 oncologists who attended the conference shows that ASCO 2019 did not disappoint.

ZoomRx, MGH, and the Sumaira Foundation Collaborate on Newly Published NMO Research

When approached by the Global Neurology Research Group at Mass General Hospital (along with the Sumaira Foundation) with the opportunity to collaborate on a global study of neuromyelitis optica (NMO), we were eager

Practicing Oncologists Weigh In on ASCO's 2019 Annual Meeting

With ASCO just days away, oncologists are divided in their outlook for this year's meeting. In our survey of 54 practicing oncologists who plan on attending the conference, half (52%) reported they expect

Breakthrough Treatments and Pharma's Pricing Dilemma - Perspective from AAN 2019

The recent 2019 AAN conference (May 4-10, Philadelphia) brought promising new data in rare diseases, generating a great deal of excitement and anticipation for new therapies.

ZoomRx Teams Up with Health Care Without Walls

Under the direction and vision of Dr. Roseanna Means, Health Care Without Walls (HCWW) has been working to provide care to homeless women and families in the greater Boston area for nearly two decades.

Welcome to Our Blog

We believe there is important work to be done at the intersection of healthcare, technology, and data. This blog will chronicle some of that work being done at ZoomRx and by others.